Atlas Trials

Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.

Clinical trial NCT01931878 · COMPLETED

Trial details

NCT number
NCT01931878
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Restless Leg Syndrome
Start date
2012-09-01
Primary completion
2015-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.